25 results
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
13 Sep 23
Regulation FD Disclosure
7:00am
Malignancy 1. NIH NCI Surveillance Cancer Facts Leukemia - AML 2. AbbVie VENCLEXTA (venetoclax) Package Insert
40 ZN-d5 + Azenosertib Combination Treatment
10-K
EX-10.12
prf0q h8e
25 Mar 21
Annual report
7:17am
10-K
gud9djnc38lh11sy3
25 Mar 21
Annual report
7:17am
8-K
EX-10.1
0ks66ud0oicrysdcl
2 Oct 20
Entry into a Material Definitive Agreement
4:51pm
424B4
510p2m
31 Jul 20
Prospectus supplement with pricing info
12:00am
DRS
EX-10.7
ld9qzgynwtjr074qtun
10 Jul 20
Draft registration statement
12:00am
DRS
EX-10.5
wu507ano7a7
10 Jul 20
Draft registration statement
12:00am
DRS
60f5bysx
10 Jul 20
Draft registration statement
12:00am
10-Q
i2hxnvyjik24b60j 31
15 May 20
Quarterly report
7:25am
424B4
ohkh dothvvge4
6 Apr 20
Prospectus supplement with pricing info
6:13am